EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting endocytosis to sensitize cancer cells to programmed cell death

Emily T Chan, Cömert Kural iD

Biochemical Society Transactions · 28.08.2024 · 52 (4) · 1703-1713

DOI: 10.1042/bst20231332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 02.08.2024. Verfasst von Emily T Chan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Biophysics Graduate Program, The Ohio State University, Columbus, OH 43210, U.S.A. Hauptthemen laut MEDLINE: Endocytosis, Neoplasms, Apoptosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evading programmed cell death (PCD) is a hallmark of cancer that allows tumor cells to survive and proliferate unchecked. Endocytosis, the process by which cells internalize extracellular materials, has emerged as a key regulator of cell death pathways in cancer. Many tumor types exhibit dysregulated endocytic dynamics that fuel their metabolic demands, promote resistance to cytotoxic therapies, and facilitate immune evasion. This review examines the roles of endocytosis in apoptotic resistance and immune escape mechanisms utilized by cancer cells. We highlight how inhibiting endocytosis can sensitize malignant cells to therapeutic agents and restore susceptibility to PCD. Strategies to modulate endocytosis for enhanced cancer treatment are discussed, including targeting endocytic regulatory proteins, altering membrane biophysical properties, and inhibiting Rho-associated kinases. While promising, challenges remain regarding the specificity and selectivity of endocytosis-targeting agents. Nonetheless, harnessing endocytic pathways represents an attractive approach to overcome apoptotic resistance and could yield more effective therapies by rendering cancer cells vulnerable to PCD. Understanding the interplay between endocytosis and PCD regulation is crucial for developing novel anticancer strategies that selectively induce tumor cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocytosisNeoplasmsApoptosisHumansAntineoplastic AgentsAnimals

Stichwörter der Autor:innen

cancercell deathendocytosisimmune evasionmembrane mechanics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Interdisciplinary Biophysics Graduate Program, The Ohio State University, Columbus, OH 43210, U.S.A.
  • Department of Physics, The Ohio State University, Columbus, OH 43210, U.S.A.

ORCID-Profile: Cömert Kural

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Chan, E. T., & Kural, C. (2024). Targeting endocytosis to sensitize cancer cells to programmed cell death. Biochemical Society Transactions, 52(4), 1703-1713. https://doi.org/10.1042/bst20231332

Vancouver

Chan ET, Kural C. Targeting endocytosis to sensitize cancer cells to programmed cell death. Biochemical Society Transactions. 2024;52(4):1703-1713. doi:10.1042/bst20231332

BibTeX
@article{Chan2024,
  author = {Chan, Emily T and Kural, Cömert},
  title = {Targeting endocytosis to sensitize cancer cells to programmed cell death},
  journal = {Biochemical Society Transactions},
  year = {2024},
  volume = {52},
  number = {4},
  pages = {1703--1713},
  doi = {10.1042/bst20231332}
}
Kostenlos starten →